Observaciones adicionales sobre la actividad neutralizante del líquido esófago-faríngeo de bovinos después de la exposición al virus de la fiebre aftosa
Further observation on neutralizing acivity of oesophageal phagyngeal fluid of cattle after exposure to foot-and-mouth disease virus
Resumo
El presente estudio mostró la especificidad de la respuesta local a los subtipos por virus de la FA. The present stydy also showed the specificity of the local response to FMD virus infection.
Assunto
Cita
Augé de Mello P, Sutmöller P. Observaciones adicionales sobre la actividad neutralizante del líquido esófago-faríngeo de bovinos después de la exposición al virus de la fiebre aftosa. Bol Cent Panam Fiebre Aftosa. 1977; 27-28: 23-24. Augé de Mello P, Sutmöller P. Further observation on neutralizing acivity of oesophageal phagyngeal fluid of cattle after exposure to foot-and-mouth disease virus. Bol Cent Panam Fiebre Aftosa. 1977; 27-28: 25-26.
Collections
Itens relacionados
Apresentado os itens relacionados pelo título, autor e assunto.
-
Dengue, chikungunya, and Zika virus infections in Latin America and the Caribbean: a systematic review
(2023-02-10)[ABSTRACT]. Objectives. To characterize the distribution profile of dengue, chikungunya, and Zika virus infections in Latin America and the Caribbean and to identify possible factors associated with the risk of dissemination ... -
Regional Update, Influenza and Other Respiratory Viruses. Epidemiological Week 6 (17 February 2023)
(Washington, D.C., PAHO, 2023-02-23)[WEEKLY SUMMARY]. North America: Influenza activity was low overall in the subregion. Influenza A(H1N1)pdm09 continued predominating with the co-circulation of A(H3N2) and B/Victoria. The SARS-CoV-2 and RSV activity ... -
Regional Update, Influenza and Other Respiratory Viruses. Epidemiological Week 8 (3 March 2023)
(Washington, D.C., PAHO, 2023-03-09)[WEEKLY SUMMARY]. North America: Influenza activity was low in the subregion. Influenza A(H3N2)pdm09 predominated, with the co-circulation of A(H1N1)pdm09 and B/Victoria. SARS-CoV-2 circulates at moderate levels and RSV ...
